These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 17869018

  • 1. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):14-22. PubMed ID: 17869018
    [Abstract] [Full Text] [Related]

  • 2. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB, Scrimger RA, Anderson SG, Kurien EC, Thompson HK, Field GC, Hanson J.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):663-73. PubMed ID: 14967418
    [Abstract] [Full Text] [Related]

  • 3. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI, Chao KS, El Naqa I, Franklin GE, Zakarian K, Vicic M, Deasy JO.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1055-69. PubMed ID: 15990009
    [Abstract] [Full Text] [Related]

  • 4. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
    Sangthawan D, Watthanaarpornchai S, Phungrassami T.
    J Med Assoc Thai; 2001 Feb 15; 84(2):195-203. PubMed ID: 11336078
    [Abstract] [Full Text] [Related]

  • 5. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):1-8. PubMed ID: 19111400
    [Abstract] [Full Text] [Related]

  • 6. Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.
    Nakamura N, Sasano N, Yamashita H, Igaki H, Shiraishi K, Terahara A, Asakage T, Nakao K, Ebihara Y, Ohtomo K, Nakagawa K.
    Auris Nasus Larynx; 2009 Jun 01; 36(3):310-3. PubMed ID: 18635328
    [Abstract] [Full Text] [Related]

  • 7. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z, Németh A, Bán A, Mukics A, Nyárády J, Ember I, Olasz L.
    Anticancer Res; 2006 Jun 01; 26(2B):1557-62. PubMed ID: 16619571
    [Abstract] [Full Text] [Related]

  • 8. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI, Chambers MS, Weber RS, Eisbruch A.
    Semin Oncol; 2004 Dec 01; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [Abstract] [Full Text] [Related]

  • 9. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.
    Hey J, Setz J, Gerlach R, Vordermark D, Gernhardt CR, Kuhnt T.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1475-80. PubMed ID: 19515505
    [Abstract] [Full Text] [Related]

  • 10. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C, LeVeque F, Swann RS, White R, Schulsinger A, Hodson DI, Meredith R, Foote R, Brachman D, Lee N.
    J Support Oncol; 2006 May 01; 4(5):252-8. PubMed ID: 16724649
    [Abstract] [Full Text] [Related]

  • 11. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP, Doornaert P, Slotman BJ, Leemans CR, Langendijk JA.
    Radiother Oncol; 2005 Nov 01; 77(2):164-71. PubMed ID: 16256229
    [Abstract] [Full Text] [Related]

  • 12. Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva.
    Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA.
    Radiother Oncol; 2007 Oct 01; 85(1):83-9. PubMed ID: 17391790
    [Abstract] [Full Text] [Related]

  • 13. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
    Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, Muscoplat CC, Gallagher SC.
    N Engl J Med; 1993 Aug 05; 329(6):390-5. PubMed ID: 8326972
    [Abstract] [Full Text] [Related]

  • 14. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
    Scrimger RA, Stavrev P, Parliament MB, Field C, Thompson H, Stavreva N, Fallone BG.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):178-85. PubMed ID: 15337554
    [Abstract] [Full Text] [Related]

  • 15. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y, Nakamatsu K, Shibata T, Kanamori S, Koike R, Okumura M, Suzuki M.
    Jpn J Clin Oncol; 2005 Jul 01; 35(7):375-9. PubMed ID: 15976068
    [Abstract] [Full Text] [Related]

  • 16. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T, Terhaard CH, Roesink JM, Braam PM, van Gils CH, Moerland MA, Raaijmakers CP.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1101-9. PubMed ID: 18472355
    [Abstract] [Full Text] [Related]

  • 17. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
    Strigari L, Benassi M, Arcangeli G, Bruzzaniti V, Giovinazzo G, Marucci L.
    Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):269-76. PubMed ID: 20100642
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia.
    Haddad P, Karimi M.
    Radiother Oncol; 2002 Jul 01; 64(1):29-32. PubMed ID: 12208571
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.